English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Feb 9, 2026
Penn Medicine scientists use advanced imaging tools for flu and cancer drug discovery
Patient Daily
| Feb 9, 2026
Study finds hundreds of potential food allergy risks but rules out vaccine connection
Patient Daily
| Feb 9, 2026
Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies
Patient Daily
| Feb 9, 2026
Penn Medicine researchers use advanced imaging tools to reveal disease mechanisms
Patient Daily
| Feb 9, 2026
FARE urges further action after Congress passes PBM reform affecting epinephrine access
Patient Daily
| Feb 9, 2026
FDA faces major leadership turnover and regulatory shifts following Trump administration actions
Patient Daily
| Feb 8, 2026
AstraZeneca acquires full rights to AbelZeta’s cancer therapy for $630 million
Patient Daily
| Feb 8, 2026
GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels
Trending
+
Pharmaceuticals
Patient Daily
| Apr 5, 2026
Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily
| Apr 7, 2026
ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+
Pharmaceuticals
Patient Daily
| Apr 1, 2026
Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+
Regulatory
Patient Daily
| Apr 8, 2026
Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'
« First
«
…
49
50
51
52
53
54
55
…
»
Last »